H.R.2338
Congress: 114th
Sponsor: Representative Pitts, Joseph R. (05/14/2015)
Committees: House - Energy and Commerce
Description: To amend the Federal Food, Drug, and Cosmetic Act to provide for the development and use of patient experience data to enhance the structured risk-benefit assessment framework, and for other purposes.
Vote Result:
Lastest Action: 05/15/2015 Referred to the Subcommittee on Health. (All Actions)
Official: H.R.2338 -- 114th Congress
- 0 Comments